SELEX Technology

Aptamer Screening ServicesSELEX technology can be used to obtain aptamers with specific binding ability to the target. Aptamers have been shown to partially replace antibodies in research and clinical applications, and are a promising technology area.

Aptamer Optimization ServicesWith the rapid development of screening technology, more and more nucleic acid aptamers have been screened and applied to many applications. In these applications, the sequences of the screened nucleic acid aptamers are generally required to be modified to meet the needs of specific applications.

Aptamer Characterization ServicesTo ensure the efficiency of aptamer applications, these selected aptamers must be highly stable, of moderate length and with good affinity. Therefore, a series of methods including structural analysis, affinity analysis and competition analysis are also required to characterize the aptamers.